Baxter International, Inc. (BAX)
16.75
+0.07
(+0.42%)
USD |
NYSE |
Apr 06, 12:43
Baxter International EPS Diluted (Quarterly) : -2.160 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 1.336 |
| Boston Scientific Corp. | 0.4493 |
| ResMed, Inc. | 2.682 |
| Abbott Laboratories | 1.030 |
| Stryker Corp. | 2.197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.035B |
| Revenue (Quarterly) | 2.974B |
| Total Expenses (Quarterly) | 4.009B |
| Enterprise Value | 16.37B |
| Gross Profit Margin (Quarterly) | 29.25% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -10.02% |
| Operating Earnings Yield | 8.00% |
| Normalized Earnings Yield | -0.5844 |